Evaluating the Efficacy and Safety of Octane Aether for Treating Chronic Low Back Pain

Официальное название

A Randomized, Double-blind, Sham-controlled Study to Evaluate the Efficacy and Safety of the Octane [Aether] Bioelectricity Device for the Management of Chronic Low Back Pain

Обзор

The goal of this clinical trial is to evaluate the safety of the Octane Aether device and to determine whether the device is effective in treating symptoms of non-specific chronic low back pain in adults. The Octane Aether is a wearable device that produces specific magnetic field outputs and is designed for daily use in a home setting. The main objectives of the trial are: * To measure the change in patient-reported pain scores during active treatment with the device compared to a sham treatment, and * To define and describe the adverse effects, if any, of the Octane Aether device when administered according to the protocol. Every participant will evaluate three active output modes and a sham output using the same device. Patient-reported outcomes will inform the effectiveness of each output mode and help identify the need for personalization in magnetic field therapy. Participants will: * Use the device at home for 60 minutes every day for 10 weeks, * Report daily pain scores using an electronic visual analog scale for pain intensity, * Visit the clinic 5 times over the course of the 13 week trial for checkups and device changes, * Respond to 3 phone calls for checkups, and * Fill various questionnaires related to disability, quality of life, and their back pain.

Вмешательства

• Устройство Pulsed electromagnetic field stimulator
  The Octane Aether is a body-worn device that generates pulsed magnetic fields of specific characteristics designed to target cellular behaviour in relation to chronic pain signalling. The device features four different output modes (3 active and 1 sham) to enable an investigation of the need for personalized pain management. The specific characteristics of the output modes are blinded from the participants and study team and are labelled here as EMF A, EMF B, EMF C, and Sham. The device firmware

Первичные конечные точки

• Change in patient-reported pain scores during active treatment compared to the sham treatment period [Срок оценки: From start of Treatment Period 1 (Week 2) to end of Treatment Period 4 (Week 9)]

Вторичные конечные точки (7)

• Adverse effects associated with the use of the Octane Aether [Срок оценки: From start of device use (Week 2) to follow-up appointment (Week 13 - end of study)]
• Effect of treatment on quality of life and disability index [Срок оценки: From end of first treatment period (Week 3) to end of fourth treatment period (Week 9)]
• Net change in perceived pain intensity (start to end) [Срок оценки: From baseline week (pre-intervention) to end of Treatment Period 4 (Week 9)]
• Net effect of intervention on disability index [Срок оценки: From baseline (Week 1) to end of Treatment Period 4 (Week 9)]
• Effect of Octane Aether EMF treatment on general health (physical and emotional) [Срок оценки: From Week 1 to Week 9]
• Longevity of the effect of Octane Aether treatment [Срок оценки: From end of device use (Week 11) to follow-up appointment (Week 13)]
• Longevity of the intervention effect on disability and quality of life [Срок оценки: From end of device use (Week 11) to follow-up appointment (Week 13)]

Критерии участия

Критерии включения

• Able to provide informed consent;
• Aged 18-65;
• Pain intensity of at least 5 on a numerical rating scale (0-10);
• Experiencing chronic low back pain that has persisted for ≥3 months;
• Pain localized primarily to the lumbar spine region;
• Conservative treatments, such as physical therapy, NSAIDs and lifestyle changes, have failed over the past 6 months. Participants are allowed to continue conservative treatments, but changes to use/frequency will be tracked; and
• Must be able to attend 5 in-person clinic appointments over the 13-week study period.

Критерии исключения

• Began using new prescription medication for pain within the past 3 months;
• Lumbar spine surgery (within the past 12 months);
• Body Mass Index (BMI)> 35. The device may have diminished effectiveness and/or may not fit individuals with high BMI;
• Presence of a cardiac pacemaker;
• Pregnancy or breastfeeding;
• Presence of ferromagnetic implants or body piercings (e.g., navel piercings) in the lumbar region, including hip implants/replacements or similar in the pelvic region, that could interfere with device function;
• Inability to put on, adjust, and/or operate the wearable device without assistance;
• Prior use of PEMF, or other electromagnetic field-emitting device, for the treatment of pain symptoms;
• No, or inconsistent, access to internet (emailed surveys are used for daily data collection); and
• Any condition or diagnosis that could in the opinion of the Principal Investigator or delegate interfere with the participant's ability to comply with study instructions, might confound the interpretation of the study results, or put the participant at risk.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Рандомизированное

Модель

Перекрёстный дизайн

Маскирование

Четверное слепое

Основная цель

Лечение

Центры проведения

Канада · 1 центр

• Kingston Orthopaedic Pain Institute — Kingston

Идентификаторы

NCT: NCT07614568 · Bioelectricity_FP01

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗